Accessibility: Skip TopNav
CUDC-907 Phase 1 and Phase 2 (Interim) Trial Results
Monotherapy in relapsed/refractory DLBCL
Format
JPEG
Source
Curis, Inc.
Downloads
Original
Large
Medium
Small